High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

UBE2D1 is frequently overexpressed in HNSCC and is associated with adverse clinical outcomes. Although its association with immunotherapy response requires further validation, UBE2D1 may be a prognostic biomarker in HNSCC.

Authors

Institutions

Publication Details

Journal
Journal of Oral Biology and Craniofacial Research
Published
2026-02-14
DOI
https://doi.org/10.1016/j.jobcr.2026.101423
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

Prathibha Prasad, Paramasivam Arumugam
Journal of Oral Biology and Craniofacial Research
Ubiquitin and proteasome pathways
article

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

Prathibha Prasad, Paramasivam Arumugam
article en

Abstract

UBE2D1 is frequently overexpressed in HNSCC and is associated with adverse clinical outcomes. Although its association with immunotherapy response requires further validation, UBE2D1 may be a prognostic biomarker in HNSCC.

Journal of Oral Biology and Craniofacial ResearchVol. 16(2)
Ajman University (AE), Saveetha University (IN)
No poverty
Openalex Percentile: Top 56%
Ubiquitin and proteasome pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer — Prathibha Prasad, Paramasivam Arumugam · Journal of Oral Biology and Craniofacial Research (2026) | TGRS Research Map | TGRS